• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在开质子泵抑制剂处方前为何要三思。

Why think twice before prescribing proton pump inhibitors.

作者信息

Lemmens An-Sofie, Huysentruyt Koen, Vandenplas Yvan

机构信息

Department of Pediatric Gastroenterology, UZ Brussels, KidZ Health Castle, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium.

Department of Pediatrics, Ziekenhuis Oost-Limburg (ZOL), Genk, Belgium.

出版信息

Eur J Pediatr. 2025 Mar 5;184(3):227. doi: 10.1007/s00431-025-06058-z.

DOI:10.1007/s00431-025-06058-z
PMID:40042553
Abstract

UNLABELLED

Proton pump inhibitors (PPIs) represent a class of drugs most prominently known for their use in acid-related disorders. Omeprazole, a drug belonging to this class, is among the top 10 most prescribed drugs in the USA. PPIs have a direct effect on the gastric pH and therefore on the gastric mucosa. This review aims to present the most common adverse effects PPIs have on the gastric mucosa in particular.

CONCLUSION

PPIs affect the composition of gut and gastric microbiota and will eventually modulate the immune response.

WHAT IS KNOWN

• Proton-pump inhibitors are amonth the most frequent prescirbed drugs becasue of their well demonstrated efficacy in acid-related disorders. • Because of their mode of action and their metabolism, a large spectrum of adversee effects have been reported.

WHAT IS NEW

• Although the well-known success of PPIs in the wide spectrum of all acid-related conditions should not refrain health care professionals to use them when indicated, insufficient attention is given to the multiple adverse effects reported for this class of drugs. • Well designed prospective trials collecting adverse effects are required, since most studies reporting adverse effects are retrospective, are biassed and have methodological issues.

摘要

未标注

质子泵抑制剂(PPIs)是一类最为人熟知的用于治疗酸相关疾病的药物。奥美拉唑属于此类药物,是美国处方量最高的十大药物之一。PPIs对胃pH值有直接影响,进而对胃黏膜产生影响。本综述旨在特别介绍PPIs对胃黏膜最常见的不良反应。

结论

PPIs会影响肠道和胃微生物群的组成,并最终调节免疫反应。

已知信息

• 质子泵抑制剂因其在酸相关疾病中已得到充分证实的疗效,是最常被处方的药物之一。• 由于其作用方式和代谢途径,已报道了广泛的不良反应。

新发现

• 尽管PPIs在各种酸相关疾病中取得了众所周知的成功,但在有指征时,医疗保健专业人员不应因此而不使用它们,然而,这类药物所报告的多种不良反应却未得到足够重视。• 需要设计良好的前瞻性试验来收集不良反应,因为大多数报告不良反应的研究都是回顾性的,存在偏差且有方法学问题。

相似文献

1
Why think twice before prescribing proton pump inhibitors.在开质子泵抑制剂处方前为何要三思。
Eur J Pediatr. 2025 Mar 5;184(3):227. doi: 10.1007/s00431-025-06058-z.
2
Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.质子泵抑制剂对消化不良患者胃黏膜相关微生物群的影响。
Appl Environ Microbiol. 2016 Oct 27;82(22):6633-6644. doi: 10.1128/AEM.01437-16. Print 2016 Nov 15.
3
Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified.质子泵抑制剂与菌群失调:现有知识和待阐明的方面。
World J Gastroenterol. 2019 Jun 14;25(22):2706-2719. doi: 10.3748/wjg.v25.i22.2706.
4
Proton pump inhibitors: actions and reactions.质子泵抑制剂:作用与反应。
Drug Discov Today. 2009 Jul;14(13-14):647-60. doi: 10.1016/j.drudis.2009.03.014. Epub 2009 Apr 8.
5
The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.胃肠道微生物群:质子泵抑制剂的作用
Curr Gastroenterol Rep. 2017 Aug;19(8):42. doi: 10.1007/s11894-017-0577-6.
6
Omeprazole-associated changes in the gastric mucosa of children.奥美拉唑对儿童胃黏膜的影响
J Clin Pathol. 2008 Jun;61(6):754-6. doi: 10.1136/jcp.2007.052480. Epub 2007 Dec 12.
7
Transmucosal gastric leak induced by proton pump inhibitors.质子泵抑制剂引起的经黏膜胃漏
Dig Dis Sci. 2009 Jul;54(7):1408-17. doi: 10.1007/s10620-008-0528-z. Epub 2008 Nov 18.
8
Drug-drug interaction profiles of proton pump inhibitors.质子泵抑制剂的药物相互作用谱。
Clin Pharmacokinet. 2010 Aug;49(8):509-33. doi: 10.2165/11531320-000000000-00000.
9
Celiac disease serology and gut microbiome following proton pump inhibitor treatment.质子泵抑制剂治疗后的乳糜泻血清学与肠道微生物群
Medicine (Baltimore). 2020 Aug 28;99(35):e21488. doi: 10.1097/MD.0000000000021488.
10
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.质子泵抑制剂使用者患 COVID-19 的风险增加。
Am J Gastroenterol. 2020 Oct;115(10):1707-1715. doi: 10.14309/ajg.0000000000000798.

引用本文的文献

1
Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS): Tiny Tummies, Key Decisions.美国食品药品监督管理局不良事件报告系统(FAERS)报告的婴儿使用质子泵抑制剂的真实世界安全性概况:小婴儿,关键决策。
Pharmaceuticals (Basel). 2025 May 16;18(5):730. doi: 10.3390/ph18050730.

本文引用的文献

1
Changes in the Gastrointestinal Microbiota Induced by Proton Pump Inhibitors-A Review of Findings from Experimental Trials.质子泵抑制剂诱导的胃肠道微生物群变化——实验性试验结果综述
Microorganisms. 2024 May 30;12(6):1110. doi: 10.3390/microorganisms12061110.
2
Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study.未指明的质子泵抑制剂起始治疗与潜在慢性肾脏病患者不良结局风险:一项全国性、回顾性队列研究。
BMJ Open. 2024 Jan 29;14(1):e078032. doi: 10.1136/bmjopen-2023-078032.
3
Proton pump inhibitors and dementia: A nationwide population-based study.
质子泵抑制剂与痴呆:一项全国性基于人群的研究。
Alzheimers Dement. 2024 Feb;20(2):837-845. doi: 10.1002/alz.13477. Epub 2023 Oct 5.
4
Can We StoP Worrying about Long-term PPIs and Gastric Cancer Risk?长期使用质子泵抑制剂(PPIs)会增加胃癌风险吗?我们是否需要为此担忧?
Cancer Epidemiol Biomarkers Prev. 2023 Sep 1;32(9):1127-1129. doi: 10.1158/1055-9965.EPI-23-0809.
5
Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children.质子泵抑制剂的使用与幼儿严重感染的风险。
JAMA Pediatr. 2023 Oct 1;177(10):1028-1038. doi: 10.1001/jamapediatrics.2023.2900.
6
Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics.质子泵抑制剂诱导的肠道菌群失调和免疫调节:益生菌的现有知识和潜在恢复作用。
Pharmacol Rep. 2023 Aug;75(4):791-804. doi: 10.1007/s43440-023-00489-x. Epub 2023 May 4.
7
Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases.接触质子泵抑制剂与儿童自身免疫性疾病的发生有关。
Front Pediatr. 2023 Mar 27;11:1157547. doi: 10.3389/fped.2023.1157547. eCollection 2023.
8
Proton Pump Inhibitors and Risk of Cardiovascular Disease: A Self-Controlled Case Series Study.质子泵抑制剂与心血管疾病风险:一项自身对照病例系列研究。
Am J Gastroenterol. 2022 Jul 1;117(7):1063-1071. doi: 10.14309/ajg.0000000000001809. Epub 2022 May 4.
9
Strategies for discontinuation of proton pump inhibitors (PPIs) in patients with long-term PPI administration: a randomized controlled trial.长期应用质子泵抑制剂(PPIs)患者停药策略的随机对照研究。
BMC Gastroenterol. 2022 Jan 15;22(1):21. doi: 10.1186/s12876-021-02086-9.
10
Use of acid-suppressive drugs and risk of fracture in children and young adults: a meta-analysis of observational studies.抑酸药物的使用与儿童和青少年骨折风险:观察性研究的荟萃分析。
Eur J Clin Pharmacol. 2022 Mar;78(3):365-373. doi: 10.1007/s00228-021-03245-3. Epub 2021 Oct 27.